Mark Kalinich News Today

 E-Mail BOSTON - Many patients with cancer receive immune checkpoint inhibitors that strengthen their immune response against tumor cells. While the medications can be life-saving, they can also cause potentially life-threatening side effects in internal organs. This double-edged sword makes it challenging for clinicians to decide who should be considered candidates for treatment. A new analysis led by researchers at Massachusetts General Hospital (MGH) indicates which patients are at elevated...

 E-Mail BOSTON - Immune checkpoint inhibitors, which boost the immune systems response against tumor cells, have transformed treatment for many advanced cancers, but short-term clinical trials and small observational studies have linked the medications with various side effects, most commonly involving the skin. A more comprehensive, population-level analysis now provides a thorough look at the extent of these side effects and provides insights on which patients may be more likely to experienc...

When the COVID-19 pandemic hit, Lake Central High School students Lilah Lopez, Thao Nguyen and Graham Weber said they were driven to learn more about the coronavirus’ effect on their community. The three seniors have since turned that curiosity into a first of its kind study researching the presence of SARS-CoV-2 antibodies in teachers and staff in a sizable Midwest public school system. Lopez said Lake Central chemistry teacher Kendal Smith first approached her this summer with the resear...